What is the Aphrodite gas field and why does it matter for SHEL?

It is an offshore reservoir straddling Cypriot and Israeli waters. A pending pact would unitize the field and send gas to Egypt for LNG exports. For Shell, this supports long‑cycle LNG supply optionality into Europe, potentially adding seasonal revenue resilience and improving portfolio flexibility during tight winter markets.

When could the Israel–Cyprus deal be signed?

Officials say talks are in the final stage, with a signing targeted as early as February. The agreement would define cross‑border sharing and development terms. Timely signing sets the stage for engineering, commercial agreements, and later investment decisions needed to bring volumes online in the 2030s.

How could German buyers benefit from EastMed LNG exports?

More EastMed LNG could increase Europe’s cargo availability in winter, easing price spikes. German utilities can receive shipments via domestic LNG terminals and optimize deliveries against TTF. While Aphrodite supplies are not imminent, clear progress today improves long‑term negotiating leverage and supply diversification for German end users.

Is SHEL stock attractive right now?

SHEL trades at $72.43 with a 3.89% dividend yield, PE 15.06, and price near its 200‑day average. Analysts lean Buy (14 Buy, 7 Hold). Upcoming earnings on 2026‑02‑05 and any Aphrodite updates are key catalysts. Consider gradual entries and the project’s long timeline when sizing positions.

Global Market Insights

SHEL Stock Today: January 22 EastMed Pact Nears for Aphrodite Gas

ByDanny Kontos January 23, 2026January 23, 2026

The Aphrodite gas field is back in focus as Israel and Cyprus near a pact to consolidate the cross‑border Aphrodite‑Ishai reservoir, with signing targeted as early as February. For German investors, this could expand EastMed LNG exports to Europe in the next decade, easing supply risks. For SHEL holders, Aphrodite ties directly to Shell’s integrated gas strategy and cash flows. We outline the deal status, why it matters for Germany, and how today’s valuation, catalysts, and risks stack up.